Moderna Boss: mRNA Jabs are “Rewriting the Genetic Code”… We Call It “Information Therapy”
In every cell, there’s this thing called messenger RNA that transmits the critical information from the DNA, our genes to the protein, which is really the stuff we’re all made out of. This is the critical information that determines what a cell will actually do. And so we think of it like an operating system. […]
Health Care Worker in Orange County, California Dies Four Days After Getting COVID-19 Vaccine
A 60-year-old health care worker died on Jan. 9, 2021 in Orange, California just four days after having received the second dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19. Tim Zook, who worked as a X-ray technician, began complaining of abdominal pain and trouble breathing about two and a half hours after […]
We Need More Details and Raw Data on Pfizer and Moderna COVID-19 Vaccines
On Nov. 26, 2020, when I raised questions1 about the results of Pfizer’s and Moderna’s COVID-19 vaccine trials, all that was in the public domain were the study protocols2 and a few press releases.3 Now, two journal publications4 and around 400 pages of summary data are available in the form of multiple reports presented by and to the U.S. Food and Drug […]
Pfizer’s Experimental COVID-19 Vaccine 90 Percent Effective?
The German biotech firm BioNTech SE issued a joint press release with its American partner Pfizer, Inc. on Nov. 9, 2020 to announce that interim analysis of a global Phase 3 study of their mRNA-based SARS-CoV-2 vaccine appeared to demonstrate an efficacy rate “above 90%”measured seven days after the second dose.1 “This is really a […]
Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]
Johnson & Johnson Pauses Phase 3 COVID-19 Vaccine Trial Following ‘Unexplained Illness’
Story Highlights Weeks after Johnson & Johnson announced that their experimental COVID-19 vaccine was in final, Phase 3 testing, the company has paused the study to evaluate an unexplained illness in a study participant. AstraZeneca’s late-stage vaccine trial is also still on pause in the U.S. after two cases of a neurological illness arose in […]
